IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$312M
AUM Growth
+$302M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
84
New
Increased
Reduced
Closed

Top Buys

1
+$26.7M
2
+$21.2M
3
+$18M
4
ALKS icon
Alkermes
ALKS
+$13.2M
5
GILD icon
Gilead Sciences
GILD
+$12.3M

Top Sells

1
+$1.94M
2
+$121K
3
+$107K
4
FOLD icon
Amicus Therapeutics
FOLD
+$94.6K
5
IMVT icon
Immunovant
IMVT
+$60K

Sector Composition

1 Healthcare 99.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$28.2M 9.03%
454,973
+432,058
2
$22.7M 7.29%
166,200
+154,593
3
$19.3M 6.17%
289,000
+270,919
4
$13.2M 4.25%
593,000
+591,481
5
$12.9M 4.13%
208,784
+199,772
6
$12.1M 3.9%
45,500
+34,894
7
$11.7M 3.76%
264,500
+253,706
8
$10.3M 3.3%
221,856
+218,253
9
$10.2M 3.27%
544,500
+536,182
10
$10.1M 3.23%
297,500
+288,896
11
$9.5M 3.05%
136,000
+126,869
12
$8.51M 2.73%
543,000
+535,710
13
$7.71M 2.47%
11,200
-2,810
14
$7.6M 2.44%
38,000
+32,458
15
$7.2M 2.31%
174,052
+164,442
16
$6.68M 2.14%
340,389
+334,442
17
$5.99M 1.92%
281,257
+277,432
18
$5.46M 1.75%
143,500
+141,924
19
$5.25M 1.68%
123,300
+116,424
20
$4.97M 1.59%
58,656
+52,055
21
$4.77M 1.53%
25,700
+16,602
22
$4.59M 1.47%
316,133
+312,373
23
$4.58M 1.47%
186,019
+176,804
24
$4.44M 1.42%
350,068
+346,203
25
$4.31M 1.38%
573,530
+567,772
1
2 3 4